H.R. 10359 — Introduced in House

I 119th CONGRESS 2d Session H. R. 10359 IN THE HOUSE OF REPRESENTATIVES September 14, 2026Mr. Bilirakis (for himself, Ms. Barragán, Mrs. Cammack, Mr. Auchincloss, Mr. Kean, and Mr. Mullin) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products. 1. Short title This Act may be cited as the Priority for Pediatric Cures Act. 2. Permanent extension of authority to award priority review vouchers for rare pediatric disease products Section 529(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)) is amended by striking paragraph (5).